P2Y12 inhibitors (class)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for P2Y12 inhibitors (class), covering 2017-10-30 to 2017-10-30. Get the full timeline:
Most recent: Clinical Trial Update: P2Y12 Inhibitors Utilization in Bifurcation and Chronic Total Occlusion PCI